SCHEMBL1299519

SCHEMBL1299519

CC1(c2nc3ccccc3[nH]2)CCNCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 4/20 0.54
PARP2 Q9UGN5 2/20 0.54
HTR3A P46098 1/20 0.46
ALDH1A1 P00352 4/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
NPSR1 Q6W5P4 3/20 0.43
KDM4E B2RXH2 2/20 0.43
TP53 P04637 2/20 0.43
PKM P14618 2/20 0.43
HSD17B10 Q99714 2/20 0.43
ABCB11 O95342 1/20 0.43
DDAH1 O94760 1/20 0.41
MASP2 O00187 1/20 0.41
MEN1 O00255 1/20 0.41
NUDT1 P36639 1/20 0.41
KMT2A Q03164 1/20 0.41
AOC3 Q16853 1/20 0.41
EPHX2 P34913 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL665135 0.91 PARP1 (0.56) PARP1PARP2HTR3AALDH1A1NPC1
SCHEMBL6755331 0.90 ALDH1A1 (0.48) PARP1PARP2ALDH1A1NPC1RAB9A
SCHEMBL6753927 0.87 BCHE (0.46) PARP1PARP2ALDH1A1NPC1RAB9A
SCHEMBL3489011 0.81 HTR3A (0.46) PARP1PARP2HTR3AALDH1A1NPC1
SCHEMBL3489392 0.80 HTR3A (0.43) PARP1PARP2HTR3AALDH1A1NPC1
SCHEMBL2309386 0.78 OPRM1 (0.56) HTR3AALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL665968 0.78 PARP1 (0.59) PARP1HTR3ARAB9ASMN1; SMN2TP53
SCHEMBL3490976 0.77 HTR3A (0.43) PARP1PARP2HTR3AALDH1A1NPC1
SCHEMBL3489582 0.77 HTR3A (0.43) HTR3AALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL664160 0.76 CHRNA7 (0.43) PARP1RAB9ADDAH1EPHX2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8609696-B2 Serotonin 5-HT2B receptor inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-12-17 US disclosed
US-20110269742-A1 Serotonin 5-HT2B Receptor Inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-11-03 US disclosed
EP-2379524-A1 SEROTONIN 5-HT2B RECEPTOR INHIBITORS Boehringer Ingelheim International GmbH (DE) 2011-10-26 EP disclosed
WO-2010080357-A1 SEROTONIN 5-HT2B RECEPTOR INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269742-A1 Serotonin 5-HT2B Receptor Inhibitors HTR2B, HTR1B, HTR3B PARP1 1759/4885PARP2 1306/4885HTR3A 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.